BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alsaadi A, Beamud B, Easwaran M, Abdelrahman F, El-Shibiny A, Alghoribi MF, Domingo-Calap P. Learning From Mistakes: The Role of Phages in Pandemics. Front Microbiol 2021;12:653107. [PMID: 33815346 DOI: 10.3389/fmicb.2021.653107] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Alsaadi A, Imam M, Alghamdi AA, Alghoribi MF. Towards promising antimicrobial alternatives: The future of bacteriophage research and development in Saudi Arabia. Journal of Infection and Public Health 2022;15:1355-1362. [DOI: 10.1016/j.jiph.2022.10.022] [Reference Citation Analysis]
2 Fang Y, Cui H, Liang X, Yu J, Wang J, Zhao G. Quaternary Ammonium-Tethered Phenylboronic Acids Appended Supramolecular Nanomicelles as a Promising Bacteria Targeting Carrier for Nitric Oxide Delivery. Polymers (Basel) 2022;14:4451. [PMID: 36298029 DOI: 10.3390/polym14204451] [Reference Citation Analysis]
3 Wang J, Meng W, Zhang K, Wang J, Lu B, Wang R, Jia K. Topically applied bacteriophage to control multi-drug resistant Pseudomonas aeruginosa-infected wounds in a New Zealand rabbit model. Front Microbiol 2022;13:1031101. [DOI: 10.3389/fmicb.2022.1031101] [Reference Citation Analysis]
4 Serwer P. A Perspective on Studies of Phage DNA Packaging Dynamics. Int J Mol Sci 2022;23:7854. [PMID: 35887200 DOI: 10.3390/ijms23147854] [Reference Citation Analysis]
5 Lopez-diaz M, Bleriot I, Pacios O, Fernandez-garcia L, Blasco L, Ambroa A, Ortiz-cartagena C, Woodford N, Ellington MJ, Tomas M. Molecular characteristics of phages located in Carbapenemase-Producing Escherichia coli clinical isolates: New Phage-Like Plasmids.. [DOI: 10.1101/2022.06.29.498070] [Reference Citation Analysis]
6 Abdelrahman F, Rezk N, Fayez MS, Abdelmoteleb M, Atteya R, Elhadidy M, El-shibiny A. Isolation, Characterization, and Genomic Analysis of Three Novel E. coli Bacteriophages That Effectively Infect E. coli O18. Microorganisms 2022;10:589. [DOI: 10.3390/microorganisms10030589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Vyas P, Harish. Anti-CRISPR proteins as a therapeutic agent against drug-resistant bacteria. Microbiol Res 2022;257:126963. [PMID: 35033831 DOI: 10.1016/j.micres.2022.126963] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Das R, Kotra K, Singh P, Loh B, Leptihn S, Bajpai U. Alternative Treatment Strategies for Secondary Bacterial and Fungal Infections Associated with COVID-19. Infect Dis Ther 2021. [PMID: 34807451 DOI: 10.1007/s40121-021-00559-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wu N, Chen LK, Zhu T. Phage therapy for secondary bacterial infections with COVID-19. Curr Opin Virol 2021;52:9-14. [PMID: 34800893 DOI: 10.1016/j.coviro.2021.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Fayez MS, Hakim TA, Agwa MM, Abdelmoteleb M, Aly RG, Montaser NN, Abdelsattar AS, Rezk N, El-Shibiny A. Topically Applied Bacteriophage to Control Multi-Drug Resistant Klebsiella pneumoniae Infected Wound in a Rat Model. Antibiotics (Basel) 2021;10:1048. [PMID: 34572629 DOI: 10.3390/antibiotics10091048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
11 Ferriol-González C, Domingo-Calap P. Phage Therapy in Livestock and Companion Animals. Antibiotics (Basel) 2021;10:559. [PMID: 34064754 DOI: 10.3390/antibiotics10050559] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]